Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gorlin's Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02100371
What this trial is testing

Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome

Who this might be right for
Basal Cell Nevus Syndrome
University Health Network, Toronto 2
Not applicableStudy completedNCT01014819
What this trial is testing

A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions

Who this might be right for
Basal Cell Carcinoma
UCSF Benioff Children's Hospital Oakland 30
Testing effectiveness (Phase 2)Study completedNCT02828111
What this trial is testing

Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinomas
PellePharm, Inc. 36
Not applicableStudy completedNCT01893892
What this trial is testing

Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

Who this might be right for
Musculoskeletal Complications
Stanford University 12
Not applicableStudy completedNCT02157623
What this trial is testing

Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome

Who this might be right for
Basal Cell Nevus Syndrome
Edward Maytin, MD, PhD 3
Testing effectiveness (Phase 2)Ended earlyNCT04155190
What this trial is testing

Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Who this might be right for
Recurrent Basal Cell Carcinoma
Sol-Gel Technologies, Ltd. 50
Not applicableUnknownNCT05898347
What this trial is testing

Nevoid Basal Cell Carcinomas in Gorlin Syndrome

Who this might be right for
Basal Cell CarcinomaGorlin Syndrome
Oslo University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT04416516
What this trial is testing

Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Who this might be right for
Basal Cell CarcinomaBasal Cell Nevus Syndrome
Ascend Biopharmaceuticals Ltd 21
Testing effectiveness (Phase 2)Study completedNCT02354261
What this trial is testing

Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

Who this might be right for
Basal Cell Carcinoma in Basal Cell Nevus Syndrome
HedgePath Pharmaceuticals, Inc. 38
Large-scale testing (Phase 3)WithdrawnNCT03070691
What this trial is testing

Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Who this might be right for
Basal Cell Carcinoma
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT02639117
What this trial is testing

Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma
University of Arizona 4
Testing effectiveness (Phase 2)Study completedNCT01815840
What this trial is testing

Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma
Hoffmann-La Roche 229
Testing effectiveness (Phase 2)Ended earlyNCT02303041
What this trial is testing

Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal CellRecurrent Skin CancerSkin Neoplasms+1 more
Anne Chang 10
Testing effectiveness (Phase 2)Study completedNCT00957229
What this trial is testing

To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS)

Who this might be right for
Basal Cell Nevus SyndromeGorlin Syndrome
UCSF Benioff Children's Hospital Oakland 41
Early research (Phase 1)Study completedNCT01463709
What this trial is testing

Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer

Who this might be right for
Basal Cell Carcinomas
UCSF Benioff Children's Hospital Oakland 4
Testing effectiveness (Phase 2)Study completedNCT00489086
What this trial is testing

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

Who this might be right for
Neoplastic Syndrome
UCSF Benioff Children's Hospital Oakland 36
Large-scale testing (Phase 3)Ended earlyNCT04308395
What this trial is testing

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Who this might be right for
Basal Cell Nevus Syndrome
Sol-Gel Technologies, Ltd. 108
Not applicableStudy completedNCT00025012
What this trial is testing

Isotretinoin in Preventing Skin Cancer

Who this might be right for
Melanoma (Skin)Non-melanomatous Skin Cancer
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Testing effectiveness (Phase 2)Study completedNCT04893486
What this trial is testing

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

Who this might be right for
BCCs in Gorlin Syndrome Patients
Palvella Therapeutics, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT02017964
What this trial is testing

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Who this might be right for
Desmoplastic/Nodular MedulloblastomaMedulloblastomaMedulloblastoma With Extensive Nodularity+1 more
Children's Oncology Group 26
Next Page